GOSS · Gossamer Bio, Inc. · Held by Funds
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, these conditions raise substantial doubt about the Company’s ability to continue as a going concern. The Company has concluded that these circumstances and the uncertainties associated with the Company’s ability to obtain additional equity or debt financing on terms that are favorable to the Company, or at all, and otherwise succeed in its future operations raise substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Nov 10, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Fund Ownership of GOSS by Fund Type
Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026Index funds and index ETFs hold 4.00% of shares outstanding.
| Fund type | Of shares outstanding | Shares |
|---|---|---|
| Index funds | 1.06% | 64,729 |
| Index ETFs | 2.94% | 179,865 |
| Active ETFs | 0.00% | 184 |
| Active funds | 0.24% | 14,720 |
| Unclassified | 0.00% | 0 |
| All registered funds | 4.24% | 259,498 |
How fund types are measured
Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.
Funds holding GOSS
35 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 6,910,934 | $1,137,540 | 0.00% | Long | 2026-06-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 2,243,305 | $369,248 | 0.00% | Long | 2026-06-30 | |
| iShares Biotechnology ETF | IBB | 1,501,116 | $247,084 | 0.00% | Long | 2026-06-30 | |
| Schwab U.S. Small-Cap ETF | SCHA | 977,847 | $166,234 | 0.00% | Long | 2026-08-31 | |
| Invesco RAFI US 1500 Small-Mid ETF | PRFZ | 556,395 | $94,309 | 0.00% | Long | 2026-07-31 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 551,694 | $93,788 | 0.00% | Long | 2026-08-31 | |
| Goldman Sachs Human Evolution ETF | — | 3,702 | $51,458 | 0.11% | Long | 2020-08-31 | |
| iShares Core S&P Total U.S. Stock Market ETF | ITOT | 294,007 | $48,394 | 0.00% | Long | 2026-06-30 | |
| Eventide Small Cap ETF | ESSC | 204,551 | $34,671 | 0.10% | Long | 2026-07-31 | |
| VANGUARD BALANCED INDEX FUND | — | 154,416 | $25,417 | 0.00% | Long | 2026-06-30 | |
| PACE Small/Medium Co Growth Equity Investments | — | 145,404 | $24,646 | 0.01% | Long | 2026-07-31 | |
| Defiance Nasdaq Junior Biotechnology ETF | — | 1,735 | $21,809 | 0.30% | Long | 2021-09-30 | |
| ProShares UltraPro Nasdaq Biotechnology | — | 1,531 | $20,102 | 0.10% | Long | 2020-02-29 | |
| Direxion Fallen Knives ETF | — | 1,730 | $19,428 | 0.81% | Long | 2022-07-31 | |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | — | 107,368 | $17,673 | 0.00% | Long | 2026-06-30 | |
| Fidelity ZERO Total Market Index Fund | FZROX | 99,976 | $16,946 | 0.00% | Long | 2026-07-31 | |
| iShares Evolved U.S. Innovative Healthcare ETF | — | 1,408 | $15,812 | 0.04% | Long | 2022-07-31 | |
| Fidelity ZERO Extended Market Index Fund | FZIPX | 74,746 | $12,669 | 0.00% | Long | 2026-07-31 | |
| BlackRock Health Sciences Term Trust | BMEZ | 60,195 | $9,908 | 0.00% | Long | 2026-06-30 | |
| Blackstone Alternative Multi-Strategy Fund | — | 59,400 | $9,777 | 0.00% | Long | 2026-06-30 | |
| Diversified Equity Alpha Master Portfolio | — | 50,820 | $8,365 | 0.00% | Long | 2026-06-30 | |
| Fidelity Flex Small Cap Index Fund | FLXSX | 35,839 | $6,075 | 0.00% | Long | 2026-07-31 | |
| Bridge Builder Small/Mid Cap Growth Fund | BBGSX | 36,524 | $6,012 | 0.00% | Long | 2026-06-30 | |
| BlackRock Health Sciences Trust | BME | 31,955 | $5,260 | 0.00% | Long | 2026-06-30 | |
| U.S. Small Cap Equity Fund | — | 30,015 | $5,088 | 0.00% | Long | 2026-07-31 | |
| Health Sciences Portfolio | — | 21,834 | $3,594 | 0.00% | Long | 2026-06-30 | |
| Invesco Nasdaq Biotechnology ETF | IBBQ | 14,495 | $2,464 | 0.00% | Long | 2026-08-31 | |
| VIP Extended Market Index Portfolio | — | 13,387 | $2,204 | 0.00% | Long | 2026-06-30 | |
| Strategic Equity Allocation Trust | JAFVX | 10,553 | $1,737 | 0.00% | Long | 2026-06-30 | |
| U.S. Small Cap Equity Fund | RIFBX | 9,057 | $1,491 | 0.00% | Long | 2026-06-30 | |
| ProShares Ultra Nasdaq Biotechnology | BIB | 8,389 | $1,426 | 0.00% | Long | 2026-08-31 | |
| Total Stock Market Index Trust | — | 5,067 | $834 | 0.00% | Long | 2026-06-30 | |
| VIP Total Market Index Portfolio | — | 4,901 | $807 | 0.00% | Long | 2026-06-30 | |
| Knights of Columbus U.S. ALL CAP INDEX FUND | — | 1,290 | $219 | 0.00% | Long | 2026-07-31 | |
| AQR Small Cap Multi-Style Fund | — | 17,778 | $2,926 | 0.00% | Short | 2026-06-30 |